December 5, 2025

Pharvaris N.V. (PHVS) Stock Analysis: Exploring a 65.95% Potential Upside in Biotech Innovation

Pharvaris N.V. (PHVS), a Swiss-based biopharmaceutical company, is capturing the attention of investors with its promising pipeline in the biotechnology sector. Specializing in therapies for rare diseases, Pharvaris focuses on..

Auna SA (AUNA) Investor Outlook: Exploring a 115% Potential Upside in the Healthcare Sector

Auna SA (AUNA), a prominent player in the healthcare sector, draws investor attention with its significant potential upside of 115.05%, as indicated by its average target price. Operating hospitals and..

Personalis, Inc. (PSNL) Stock Analysis: Navigating the Genomic Frontier with a 4.96% Upside

Personalis, Inc. (NASDAQ: PSNL) is making waves in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Fremont, California, the company is at the forefront of genomic..

MeiraGTx Holdings (MGTX): Investor Outlook with a 219.77% Potential Upside

MeiraGTx Holdings plc (NASDAQ: MGTX) offers a compelling narrative for investors searching for high-growth opportunities within the biotechnology sector. The U.S.-based clinical-stage gene therapy company is pushing the boundaries of..

Cel-Sci Corporation (CVM) Stock Analysis: Unpacking the 575% Upside Potential

Cel-Sci Corporation (NYSEAMERICAN: CVM), a biotechnology firm focused on innovative cancer and immune system treatments, has captured investor attention with its remarkable potential upside of 575.68%. Headquartered in Vienna, Virginia,..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating a 15.82% Upside Potential Amidst Challenges

Ginkgo Bioworks Holdings, Inc. (NASDAQ: DNA) is a pioneering entity in the biotechnology industry, based in Boston, Massachusetts. The company is making strides in the realm of cell programming through..

Semler Scientific, Inc. (SMLR) Stock Analysis: Exploring a 223% Potential Upside in Healthcare Innovation

Semler Scientific, Inc. (SMLR), a player in the healthcare sector focusing on medical devices, is making waves with its innovative approach to enhancing clinical effectiveness through technology solutions. Based in..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Navigating a Challenging Landscape with Strategic Collaborations

Investors eyeing Fortrea Holdings Inc. (FTRE), a burgeoning player in the biotechnology sector, may find themselves at a crossroads when considering its market position. With its headquarters in Durham, North..

Definitive Healthcare Corp. (DH) Stock Analysis: Examining a Potential 58% Upside in Healthcare Intelligence

Definitive Healthcare Corp. (NASDAQ: DH), a prominent player in the health information services industry, offers investors a compelling opportunity within the healthcare sector. The company provides a comprehensive software-as-a-service (SaaS)..

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: Exploring a Potential 70% Upside in the Biotech Sector

Praxis Precision Medicines, Inc (NASDAQ: PRAX) is making waves in the healthcare sector with its innovative approach to tackling central nervous system (CNS) disorders. As a clinical-stage biopharmaceutical company, Praxis..

Immatics N.V. (IMTX) Stock Analysis: Biotech Innovator with a 57.96% Upside Potential

Immatics N.V. (NASDAQ: IMTX), a clinical-stage biopharmaceutical company based in Tübingen, Germany, is capturing investor attention with its promising research and development in T cell redirecting immunotherapies aimed at treating..

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: Biotechnology Pioneer with a 40% Potential Upside

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a clinical-stage biotechnology company, is capturing investor attention with its promising pipeline targeting neurodegenerative diseases. Headquartered in Cambridge, Massachusetts, this healthcare sector player is making..

Maravai LifeSciences Holdings (MRVI) Stock Analysis: Evaluating Growth Potential Amidst Challenging Metrics

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a prominent player in the biotechnology sector, has captured the attention of investors with its innovative contributions to the healthcare industry. Specializing in nucleic..

Replimune Group, Inc. (REPL) Stock Analysis: Exploring a 19% Potential Upside in Biotechnology

Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company, is capturing investor attention with its innovative approach to oncolytic immunotherapies for cancer treatment. With a market capitalization of $826.01 million,..

Cogent Biosciences, Inc. (COGT) Investor Outlook: Strong Buy Ratings and 20% Upside Potential

Cogent Biosciences, Inc. (NASDAQ: COGT) is emerging as a captivating investment opportunity in the biotechnology sector. With a market capitalization of $6.03 billion, this Waltham, Massachusetts-based company is making significant..

GH Research PLC (GHRS) Investor Outlook: Potential 97.88% Upside with Strong Buy Ratings

GH Research PLC (NASDAQ: GHRS) has piqued investor interest with its promising pipeline in the biotechnology sector, particularly focusing on innovative treatments for depression. This Dublin, Ireland-based company is making..

Tyra Biosciences (TYRA) Stock Analysis: Biotechnology Innovator with a 44.73% Potential Upside

Tyra Biosciences, Inc. (NASDAQ: TYRA) is swiftly capturing the attention of investors with its promising potential upsides in the biotechnology sector. Positioned as a clinical-stage biotechnology company, Tyra Biosciences focuses..

Nuvation Bio Inc. (NUVB) Stock Analysis: 23% Potential Upside for This Biotech Innovator

For investors with an eye on innovative biopharmaceutical companies, Nuvation Bio Inc. (NASDAQ: NUVB) presents a compelling opportunity in the healthcare sector. With a market capitalization of $2.85 billion, this..

Enhabit, Inc. (EHAB) Stock Analysis: Navigating the Healthcare Sector with a Modest Upside Potential

Enhabit, Inc. (NASDAQ: EHAB), a prominent player in the healthcare sector, operates within the medical care facilities industry, focusing on providing comprehensive home health and hospice services across the United..

Ardelyx, Inc. (ARDX) Investor Outlook: Exploring a Potential 95.95% Upside in Biotechnology

Ardelyx, Inc. (NASDAQ: ARDX) stands as a compelling prospect within the biotechnology sector, driven by its innovative approach to addressing unmet medical needs. With a robust market capitalization of $1.44..

Search

Funds

December 5, 2025

Search

Funds

December 5, 2025

FTSE 100

Funds